SAMHSA Amends 42 CFR Part 2, Seeking to Better Align the Regulation with Today’s Health Care Delivery System

by Stoel Rives LLP
Contact

Stoel Rives LLP

In another step towards modernizing the privacy rule designed to protect patient substance abuse records, the Department of Health and Human Services Substance Abuse and Mental Health Services Administration (“SAMHSA”) published a final rule on January 3, 2018, finalizing modifications initiated last year and amending 42 CFR Part 2 (“Part 2”) to make it easier for health care providers to disclose those records.[1]  The final rule, which becomes effective February 2, 2018, addresses when health care providers may use and disclose substance abuse records for purposes of payment, health care operations, and audits and evaluations, and better aligns Part 2 with requirements under HIPAA.  It also includes an option for health care providers to use a shorter notice of prohibition on re-disclosure.

Part 2 protects the confidentiality of records relating to the identity, diagnosis, prognosis, or treatment of any patient records that are maintained in connection with the performance of any federally assisted program or activity relating to substance use disorder education, prevention, training, treatment, rehabilitation, or research.  Prior to the new rulemaking, Part 2 only allowed a federally assisted substance use disorder program to release patient identifying information with the individual’s written consent, pursuant to a court order, or under a few limited exceptions.

SAMHSA has recognized a need to update Part 2 to provide for greater flexibility in disclosing patient identifying information within today’s health care delivery system while still retaining important privacy protections for individuals seeking treatment for substance use disorders.  To that end, the January 3, 2018 final rule includes the following major substantive changes:

  1. Abbreviated Notice of Prohibition on Re-Disclosure (42 CFR § 2.32(a)).  One of the most administratively onerous aspects of Part 2 is the requirement to provide a detailed notice prohibiting re-disclosure of records with each disclosure of substance abuse records made with a patient’s written consent.  See 42 CFR § 2.32(a).  The final rule gives health care providers the option to use an abbreviated notice, stating: “42 CFR part 2 prohibits unauthorized disclosure of these records.”  SAMHSA added the option to address concerns about character limits in free-text fields within electronic health record systems.
  2. Additional Disclosures for Payment and Health Care Operations Activities (42 CFR § 2.33(b), (c)).  The final rule allows a person or entity that receives substance abuse records for purposes of payment and health care operations pursuant to a patient consent to re-disclose records as may be necessary to its “contractors, subcontractors, or legal representatives to carry out payment and/or health care operations” on its behalf.  See 42 CFR § 2.33(b).  The text of the regulation itself does not identify what activities constitute “payment and/or health care operations,” but SAMHSA included in the preamble to the final rule a non-exhaustive list of such permissible activities that incorporates many of the activities included in the definitions of such terms in the HIPAA Privacy Rule at 45 CFR § 164.501.  Importantly, SAMHSA expressly stated that this authority for these lawful holders to re-disclose records under § 2.33(b) “is not intended to cover care coordination or case management” and that re-disclosures to “carry out such purposes are not permitted” under this regulation.  Also, re-disclosures to contractors, subcontractors, or legal representatives are not permitted for activities related to a patient’s diagnosis, treatment, or referral for treatment.

    The final rule also provides that a lawful holder that re-discloses substance abuse records to contractors, subcontractors, or voluntary legal representatives[2] for payment and health care operations activities must enter into a written contract with the recipient requiring the recipient to comply with the provisions of Part 2.  42 CFR § 2.33(c).  Although SAMHSA declined to provide specific contract terms, it listed requirements that would apply to the lawful holder, including the requirement to (1) furnish recipients with the notice required under § 2.33; (2) implement appropriate safeguards to prevent unauthorized uses and disclosures; and (3) report any unauthorized uses, disclosures, or breaches of patient identifying information to the lawful holder.  These contracts must be in effect by February 2, 2020.

  3. Additional Disclosures for Federal, State, or Local Governmental Agency Audits or Evaluations (42 CFR § 2.53).  The final rule clarifies that federal, state, and local governments providing financial assistance to, or regulating the activities of, health care providers subject to Part 2 may perform audits or evaluations of those programs and may access substance abuse records in connection with such an audit or evaluation.  See 42 CFR § 2.53.  The final rule also specifies that audits and evaluations may be performed by contractors, subcontractors, or legal representatives on behalf of third-party payers or quality improvement organizations, and that if disclosures are made for a Medicare, Medicaid, or CHIP audit or evaluation (including a civil investigation or administrative remedy), further disclosures may be made to a contractor, subcontractor, or legal representative to carry out the audit or evaluation.

In adopting the foregoing modifications, SAMHSA explained that it has attempted to align Part 2 with HIPAA, the HITECH Act, and their implementing regulations to the extent feasible, while also noting that Part 2 is separate and distinct from those other privacy laws.

SAMHSA plans to hold a public meeting to obtain additional input about the effect of Part 2 on patient privacy, health outcomes, and patient care.  The public meeting tentatively is scheduled for January 31, 2018.


[1] 83 Fed Reg 239 (January 3, 2018).
[2] This requirement does not apply to a legal representative that is required to represent the lawful holder by law.

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Stoel Rives LLP | Attorney Advertising

Written by:

Stoel Rives LLP
Contact
more
less

Stoel Rives LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.